Vaccine Slows Return of Pancreatic Cancer in Early Trial

THURSDAY, May 11, 2023 – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial. The mRNA vaccine, which was tailored to the genetic makeup of each patient ' s tumor, worked in half...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news